These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 29431739

  • 1. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
    Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, Lorenzin F, Prandi D, Romanel A, Demichelis F, Inga A, Cereseto A.
    Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739
    [Abstract] [Full Text] [Related]

  • 2. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A, Ishida T, Yoshimura M, Kimura Y, Sawa S.
    Plant Cell Physiol; 2019 Oct 01; 60(10):2255-2262. PubMed ID: 31198958
    [Abstract] [Full Text] [Related]

  • 3. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
    Wang GH, Wang CM, Wu XJ, Chu T, Huang DW, Li J.
    Mol Biol (Mosk); 2024 Oct 01; 58(1):157-159. PubMed ID: 38943587
    [Abstract] [Full Text] [Related]

  • 4. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9.
    Choi GCG, Zhou P, Yuen CTL, Chan BKC, Xu F, Bao S, Chu HY, Thean D, Tan K, Wong KH, Zheng Z, Wong ASL.
    Nat Methods; 2019 Aug 01; 16(8):722-730. PubMed ID: 31308554
    [Abstract] [Full Text] [Related]

  • 5. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
    Yang ZX, Fu YW, Zhao JJ, Zhang F, Li SA, Zhao M, Wen W, Zhang L, Cheng T, Zhang JP, Zhang XB.
    Genomics Proteomics Bioinformatics; 2023 Dec 01; 21(6):1206-1220. PubMed ID: 36549468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK.
    Nature; 2016 Jan 28; 529(7587):490-5. PubMed ID: 26735016
    [Abstract] [Full Text] [Related]

  • 11. PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.
    Acharya S, Ansari AH, Kumar Das P, Hirano S, Aich M, Rauthan R, Mahato S, Maddileti S, Sarkar S, Kumar M, Phutela R, Gulati S, Rahman A, Goel A, Afzal C, Paul D, Agrawal T, Pulimamidi VK, Jalali S, Nishimasu H, Mariappan I, Nureki O, Maiti S, Chakraborty D.
    Nat Commun; 2024 Jun 28; 15(1):5471. PubMed ID: 38942756
    [Abstract] [Full Text] [Related]

  • 12. Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.
    Kang M, Zuo Z, Yin Z, Gu J.
    J Chem Inf Model; 2022 Jun 27; 62(12):3057-3066. PubMed ID: 35666156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increasing the specificity of CRISPR systems with engineered RNA secondary structures.
    Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA.
    Nat Biotechnol; 2019 Jun 27; 37(6):657-666. PubMed ID: 30988504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
    Cerchione D, Loveluck K, Tillotson EL, Harbinski F, DaSilva J, Kelley CP, Keston-Smith E, Fernandez CA, Myer VE, Jayaram H, Steinberg BE.
    PLoS One; 2020 Jun 27; 15(4):e0231716. PubMed ID: 32298334
    [Abstract] [Full Text] [Related]

  • 19. DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 Type II-C system.
    Fedorova I, Arseniev A, Selkova P, Pobegalov G, Goryanin I, Vasileva A, Musharova O, Abramova M, Kazalov M, Zyubko T, Artamonova T, Artamonova D, Shmakov S, Khodorkovskii M, Severinov K.
    Nucleic Acids Res; 2020 Feb 28; 48(4):2026-2034. PubMed ID: 31943070
    [Abstract] [Full Text] [Related]

  • 20. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
    Li F, Hung SSC, Mohd Khalid MKN, Wang JH, Chrysostomou V, Wong VHY, Singh V, Wing K, Tu L, Bender JA, Pébay A, King AE, Cook AL, Wong RCB, Bui BV, Hewitt AW, Liu GS.
    Hum Gene Ther; 2019 Nov 28; 30(11):1349-1360. PubMed ID: 31373227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.